Scientific Research and Essays

  • Abbreviation: Sci. Res. Essays
  • Language: English
  • ISSN: 1992-2248
  • DOI: 10.5897/SRE
  • Start Year: 2006
  • Published Articles: 2750

Full Length Research Paper

High sensitive C-reactive protein (hs-CRP) level and lipid profiles of healthy volunteers with prehypertension

Yuttana Sudjaroen
  • Yuttana Sudjaroen
  • Faculty of Science and Technology, Suan Sunandha Rajabhat University, Bangkok, Thailand 10300.
  • Google Scholar


  •  Received: 18 December 2014
  •  Accepted: 20 February 2015
  •  Published: 28 February 2015

References

Armani A, Becker RC (2005). The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part II. Am. Heart J. 149(6):977-983.
Crossref
 
Asegaonkar SB, Marathe A, Tekade ML, Cherekar L, Bavikar J, Bardapurkar J, Ajay R (2011). High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile. J. Diab. Complication 25(6):368-370.
Crossref
 
Celik T, Yuksel UC, Demirkol S, Bugan B, Iyisoy A, Kabul HK, Kilic S, Fici F, Yaman H (2011). Relationship between increased systemic inflammation and impaired aortic elasticity in young patients with prehypertension. Blood Press. Monit. 16(2):55-61.
Crossref
 
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003). National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 289(19):2560-2572.
Crossref
 
Corrado E, Novo S (2005). Role of inflammation and infection in vascular disease. Acta Chir. Belg. 105(6):567-579.
 
Fantuzzi G (2005). Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115(5):911-919.
Crossref
 
Horowitz LG (2008). Reference intervals: practical aspects. Electronic J. Int. Fed. Clin. Chem. Lab. Med. 19(2):1-11.
 
Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C (2005). Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J. Surg. Res. 126(1):121-129.
Crossref
 
Moreno-Aliaga MJ, Campion J, Milagro FI, Berjon A, Martinez JA (2005). Adiposity and proinflammatory state: The chicken or the egg. Adipocytes 1:1-16.
 
Nakapong R, Meerit S (2006). Cardiovascular diseases report in 2006. Department of Disease Control, Ministry of Public Health, Thailand.
 
Pearson TA, Mensah GA, Alexander, RW Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499-511.
Crossref
 
Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF (2006). Value of serum glycated albumin & high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes. Cardiovasc. Diabetol. 5:27.
Crossref
 
Ridker PM (1998). Inflammation, infection, and cardiovascular risk: How good is the clinical evidence? Circulation 97(17):1671-1674.
Crossref
 
Ridker PM (2003). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363-369.
Crossref
 
Rogowski O, Shapira I, Toker S, Melamed S, Shirom A, Zeltser D, Berliner S (2007). Very low C-reactive protein in apparently healthy individuals: Physiological status or just a reflection of an improved health profile. Biomarkers 12(6):645-656.
Crossref
 
Soriano-Guillén L, Hernández-García B, Pita J, Domínguez-Garrido N, Del Río-Camacho G, Rovira A (2008). High-sensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur. J. Endocrinol. 159(1):R1-4.
Crossref
 
Vettor R, Milan G, Rossato M, Federspil G (2005). Adipocytokines and insulin resistance. Aliment. Pharmacol. Ther. 22(Suppl 2):3-10.
Crossref
 
Xu H, Barnes GT, Yang Q, Tang G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112(12):1821-1830.
Crossref